Skip to content

Med-Max

Active
Private limited companyfounded 20242 yrs activeChaussée de Namur 247/C2, 1300 Wavre, BelgiumKBO/BCE: BE 1013.151.835
Summary

The computed 12-month bankruptcy probability of Med-Max is 2.6% (moderate). The 2025 annual accounts show equity of €173,536 and a net result of €168,536. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €14,000 at 30 days only on tighter terms
Liquidity ample (current ratio 3.98; short-term debt: 23.1% and cash: 77.2% of total assets), and 23.1% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
76.9%
Return on assets
74.7%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-09-2026, 45 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
45 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 4 September 2024, Med-Max was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€173,536
Total assets
€225,675
Net result
€168,536
Working capital
€155,123

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €225,675
Fixed assets €18,413
Current assets €207,262
Equity and liabilities €225,675
Equity €173,536
Debt €52,138
Debt finances 23.1% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€245,795
Cash flow
€171,589
Current ratio
3.98
Debt to equity
0.30
ROE
97.1%
ROA
74.7%
Interest coverage
159.63
Debt ≤ 1 year
€52,138
Income taxes
€72,668

Peer companies

Historical observation

Of the 39,275 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
2.2% stopped otherwise
96% still going

A further 0.4% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 2.6% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,275 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 40 lines
Balance sheet Code2025
Assets
Total assets20/58€225,675
Fixed assets21/28€18,413
Tangible fixed assets22/27€17,213
Furniture and vehicles24€11,786
Other tangible fixed assets26€5,427
Financial fixed assets28€1,200
Current assets29/58€207,262
Amounts receivable after more than one year29€7,000
Other amounts receivable291€7,000
Amounts receivable within one year40/41€1,390
Trade receivables40€1,390
Cash at bank and in hand54/58€174,153
Deferred charges and accrued income490/1€24,719
Equity and liabilities
Total equity and liabilities10/49€225,675
Equity10/15€173,536
Contributions10/11€5,000
Reserves13€168,536
Distributable reserves133€168,536
Amounts payable17/49€52,138
Amounts payable within one year42/48€52,138
Trade debts44€3,043
Suppliers440/4€3,043
Taxes, remuneration and social security45€47,668
Taxes450/3€47,668
Other amounts payable47/48€1,427
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,053
Other operating charges640/8€6,109
Gross operating margin9900€251,905
Operating profit (loss)9901€242,742
Financial income75/76B€2
Recurring financial income75€2
Financial charges65/66B€1,540
Recurring financial charges65€1,540
Profit (loss) for the period before taxes9903€241,205
Income taxes67/77€72,668
Profit (loss) for the period9904€168,536
Profit (loss) for the period to be appropriated9905€168,536
Appropriation of the result
Profit (loss) to be appropriated9906€168,536
Transfer to equity691/2€168,536
To other reserves6921€168,536

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,053
Other operating charges640/8€6,109
Gross operating margin9900€251,905
Operating profit (loss)9901€242,742
Financial income75/76B€2
Recurring financial income75€2
Financial charges65/66B€1,540
Recurring financial charges65€1,540
Profit (loss) for the period before taxes9903€241,205
Income taxes67/77€72,668
Profit (loss) for the period9904€168,536
Profit (loss) for the period to be appropriated9905€168,536
Line2025
Assets
Total assets20/58€225,675
Fixed assets21/28€18,413
Tangible fixed assets22/27€17,213
Furniture and vehicles24€11,786
Other tangible fixed assets26€5,427
Financial fixed assets28€1,200
Current assets29/58€207,262
Amounts receivable after more than one year29€7,000
Other amounts receivable291€7,000
Amounts receivable within one year40/41€1,390
Trade receivables40€1,390
Cash at bank and in hand54/58€174,153
Deferred charges and accrued income490/1€24,719
Equity and liabilities
Total equity and liabilities10/49€225,675
Equity10/15€173,536
Contributions10/11€5,000
Reserves13€168,536
Distributable reserves133€168,536
Amounts payable17/49€52,138
Amounts payable within one year42/48€52,138
Trade debts44€3,043
Suppliers440/4€3,043
Taxes, remuneration and social security45€47,668
Taxes450/3€47,668
Other amounts payable47/48€1,427
Line2025
Profit (loss) for the period9904€168,536
+ Depreciation and write-downs630€3,053
Operating cash flow (approximation)€171,589

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
14-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 45 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2024
seat establishment approximate The establishment unit on the map
1 establishment unit
Med-Max
Chaussée de Namur 247/C2, 1300 WavreGeneral medical practice
since 20242.363.641.659

Identification & contact

Identification
Legal formPrivate limited company
Founded04-09-2024
Fiscal year end31-12
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.